Practitioner Training – Full Day

Customized practitioner training for licensed MD, ND, DO, NP etc. with Dr. Akbar Khan in your own office. One full day (8 hours).
MD - Medical Doctor (University of Toronto)
IMD - Integrative Medical Doctor (conferred by the World Organization of Natural Medicine)
DHS - Doctor of Humanitarian Service (conferred by the World Organization of Natural Medicine)
FAAO - Fellow of the American Academy of Ozone Therapy

Choose from topics such as:
Metabolic cancer therapy with oral or intravenous DCA, oxaloacetate, NAD+, artesunate, high dose vitamin C, DMSO / bicarbonate, mistletoe. Ozone therapy such as Zotzmann multi-pass hyperbaric EBOO, ozonated saline infusion, pleural or peritoneal insufflation, Prolozone (trademark of Dr. Frank Shallenberger), ear ozone and other techniques. In-office intravenous medication compounding. Use of SteriComp machine for compounding. Use of Low Dose naltrexone. Use of off-label high dose anti-parasite medications. Framework for chronic disease management including CVD, autoimmune, C19 vaccine injury, chronic infections and others.

Maintain a focus on natural or integrative methods. Includes appropriate P+P manual entries, sources of specific medications that are difficult to obtain, educational patient handouts, sample consent forms and a certificate for successful course completion.

Dr. Khan is considered to be one of the world's foremost metabolic cancer therapy experts, and a leading integrative medicine expert. He has treated the largest number of cancer patients in the world with dichloroacetate metabolic cancer therapy, and has published the most peer-reviewed human cases of successful metabolic cancer therapy in the world.

Dr. Khan has authored several leading publications about the clinical use of dichloroacetate sodium (DCA) as a metabolic cancer therapy in humans. Dr. Khan was the first in the world to publish in peer-reviewed journals:

• quality of life benefits of DCA (elimination of severe pain with cancer of unknown primary)
• synergism of DCA with radiation leading to cure (stage 4 kidney cancer)
• effectiveness of intravenous DCA in advanced cancers (case series examining sarcoma, pancreatic neuroendorcine carcinoma and colon carcinoma)
• long-term disease stabilization potential of DCA (case reports of stage 4 melanoma and colon carcinoma)
• clinical success of simultaneous glucose and glutamine blocking (as proposed by Prof. Thomas Seyfried)
• proposed addition to the cancer staging system to include measurement of cancer spreading through the blood
• proposed novel prostate cancer primary prevention method based on detection and treatment of chronic infectious prostatitis
• case report of long-term complete remission of adenoid cystic carcinoma using only low dose naltrexone (LDN) and high dose vitamin D